YOLFTbeta
Stenocare AS

Stenocare AS

STENO · CO · Healthcare / Drug Manufacturers - Specialty & Generic

0.672DKK+0.01 (+2.13%)

Price History

Full chart

Market Stats

Previous Close0.658
Open0.632
Day Range0.63 – 0.672
52-Week Range0.656 – 2.80
Volume114.03K
Market Cap28.94M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.03
Dividend Yield0.00%
Beta0.47
50-Day Avg0.9374
200-Day Avg1.14

About

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Thomas Skovlund Schnegelsberg
  • Employees4
  • HeadquartersNyholmsvej 4, Randers, Denmark, 8930, Denmark
  • Websitehttps://stenocare.dk

Leadership

  • Mr. Thomas Skovlund SchnegelsbergCEO, Co-Founder & Member of Executive Board · b. 1965
  • Mr. Rolf Steno PetersenCo-Founder, Chief Commercial Officer & Director · b. 1965
  • Mr. Peter Bugge JohansenChief Financial Officer · b. 1962

Financials

Income Statement

Currency: DKK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.14M8.78M198.45K1.57M4.49M3.76M2.23M7.02M
Growth (%)-+111.94%-97.74%+693.65%+185.05%-16.30%-40.60%+214.54%
Cost of Revenue7.74M11.41M12.27M15.65M10.90M10.18M20.71M8.83M
Gross Profit-3.59M-2.63M-12.07M-14.08M-6.41M-6.42M-18.47M-1.81M
Gross Margin-86.67%-29.94%-6082.87%-893.87%-142.77%-170.84%-827.64%-25.80%
Operating Expense0-7.00M-31.84K-32.15K10.12M9.53M14.62M-38.00K
Operating Income-3.59M4.37M-12.04M-14.05M-16.53M-15.95M-33.09M-1.77M
Operating Margin-86.67%49.72%-6066.82%-891.83%-368.13%-424.36%-1482.52%-25.26%
EBITDA-3.60M4.43M-11.80M-12.96M-13.28M-12.56M-24.20M-1.70M
EBITDA Margin-86.94%50.39%-5945.56%-822.79%-295.80%-334.30%-1084.13%-24.27%
Net Income-3.28M1.70M-11.79M-12.73M-16.30M-17.57M-34.49M-2.39M
Net Income Margin-79.05%19.38%-5939.17%-808.41%-363.13%-467.55%-1545.07%-34.05%
Interest Expense12.57K2.12M1.68M213.23K1.29M2.88M1.54M658.25K
Interest Expense % of Total Revenue0.30%24.15%846.34%13.54%28.83%76.53%68.79%9.38%

Balance Sheet

Currency: DKK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets21.71M31.61M56.34M43.94M39.60M38.12M19.69M12.64M
Total Liabilities1.24M18.13M3.77M3.69M15.46M12.30M23.17M3.17M
Total Equity20.47M13.47M52.57M40.24M24.14M25.82M-3.47M9.47M
Cash18.15M21.73M26.36M11.72M4.43M9.50M1.38M787.40K
Total Debt-16.64M79.97K1.24M11.31M9.68M3.73M1.99M
Net Debt-18.15M-5.09M-26.28M-10.48M6.88M184.17K2.35M1.20M

Cash Flow

Currency: DKK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.57M-2.54M-12.70M-13.34M-15.03M-10.04M-7.14M-7.21M
Investing Cash Flow-27.04K-8.88M-18.54M-2.54M-936.84K-176.64K-28.21K-364.63K
Financing Cash Flow23.75M15.00M35.88M1.24M8.68M15.29M-948.55K6.98M
Capital Expenditure21.04K8.39M18.54M3.27M935.87K176.39K44.41K4
Free Cash Flow-5.60M-10.94M-31.24M-16.61M-15.97M-10.22M-7.19M-7.21M
FCF to OCF100.38%429.91%245.95%124.51%106.23%101.76%100.62%100.00%

Earnings

Report DateJun 30, 2020Sep 30, 2020Dec 31, 2020May 6, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------
EPS Actual-0.15-0.10-0.18-0.26-0.10-0.13-0.22-0.18-0.22-0.20-0.15-0.21-0.16-0.22-0.15-0.11-0.12-0.13-0.62-0.05-0.00-0.00-0.00-0.01-0.01
Surprise-------------------------
Timing-------------------------

Key Statistics & Ratios

Market Cap28.94M
Enterprise Value39.91M
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.51
Price / Book4.73
EPS-0.03
Book Value0.209
Revenue (TTM)11.52M
Gross Profit (TTM)3.34M
EBITDA187.62K
Profit Margin-9.83%
Operating Margin-8.40%
Return on Equity-20.83%
Return on Assets-3.81%
Shares Outstanding43.20M
Shares Float33.00M
Beta0.47
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jan 3, 2025111:62
  • May 22, 2023803:758
  • May 25, 2020187:168